Eicosanoid storm in infection and inflammation (original) (raw)

• Funk, C. D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871–1875 (2001).
  CAS PubMed Google Scholar
• Buczynski, M. W., Dumlao, D. S. & Dennis, E. A. Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology. J. Lipid Res. 50, 1015–1038 (2009). A paper that describes and compares the genes and enzymes responsible for the formation of major and minor eicosanoids and related lipid mediators from arachidonic acid and related PUFAs in humans, mice and rats.
  CAS PubMed PubMed Central Google Scholar
• Gross, O., Thomas, C. J., Guarda, G. & Tschopp, J. The inflammasome: an integrated view. Immunol. Rev. 243, 136–151 (2011).
  CAS PubMed Google Scholar
• Latz, E., Xiao, T. S. & Stutz, A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13, 397–411 (2013).
  CAS PubMed Google Scholar
• Norris, P. C., Gosselin, D., Reichart, D., Glass, C. K. & Dennis, E. A. Phospholipase A2 regulates eicosanoid class switching during inflammasome activation. Proc. Natl Acad. Sci. USA 111, 12746–12751 (2014). A study demonstrating macrophage reprogramming from pro-inflammatory to pro-resolution mediator synthesis that parallels classic inflammasome activation: a link between inflammation and resolution, as well as between eicosanoid and cytokine storms.
  CAS PubMed Google Scholar
• Harkewicz, R. & Dennis, E. A. Applications of mass spectrometry to lipids and membranes. Annu. Rev. Biochem. 80, 301–325 (2011).
  CAS PubMed PubMed Central Google Scholar
• Dumlao, D. S., Buczynski, M. W., Norris, P. C., Harkewicz, R. & Dennis, E. A. High-throughput lipidomic analysis of fatty acid derived eicosanoids and _N_-acylethanolamines. Biochim. Biophys. Acta 1811, 724–736 (2011).
  CAS PubMed PubMed Central Google Scholar
• Serhan, C. N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92–101 (2014). A definitive review of inflammation resolution and the biosynthesis, receptor signalling and biological roles of the lipid mediators involved.
  CAS PubMed PubMed Central Google Scholar
• Quehenberger, O. & Dennis, E. A. The human plasma lipidome. New Engl. J. Med. 365, 1812–1823 (2011). A comprehensive analysis and survey of the diversity of lipid species in plasma and their roles as participants in and biomarkers for a wide range of human diseases.
  CAS PubMed Google Scholar
• Wada, M. et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J. Biol. Chem. 282, 22254–22266 (2007).
  CAS PubMed Google Scholar
• Nebert, D. W. & Dalton, T. P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat. Rev. Cancer 6, 947–960 (2006).
  CAS PubMed Google Scholar
• Brash, A. R. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274, 23679–23682 (1999).
  CAS PubMed Google Scholar
• Sala, A., Folco, G. & Murphy, R. C. Transcellular biosynthesis of eicosanoids. Pharmacol. Rep. 62, 503–510 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ueno, N., Takegoshi, Y., Kamei, D., Kudo, I. & Murakami, M. Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem. Biophys. Res. Commun. 338, 70–76 (2005).
  CAS PubMed Google Scholar
• Newcomer, M. E. & Gilbert, N. C. Location, location, location: compartmentalization of early events in leukotriene biosynthesis. J. Biol. Chem. 285, 25109–25114 (2010).
  CAS PubMed PubMed Central Google Scholar
• Dennis, E. A., Cao, J., Hsu, Y. H., Magrioti, V. & Kokotos, G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem. Rev. 111, 6130–6185 (2011). A complete review of the PLA2 superfamily of enzymes that initiate the release of arachidonic acid for eicosanoid formation, including a discussion of their biological roles and related therapeutic intervention strategies.
  CAS PubMed PubMed Central Google Scholar
• Vane, J. R. Biomedicine. Back to an aspirin a day? Science 296, 474–475 (2002).
  CAS PubMed Google Scholar
• Rajakariar, R., Yaqoob, M. M. & Gilroy, D. W. COX-2 in inflammation and resolution. Mol. Interv. 6, 199–207 (2006).
  CAS PubMed Google Scholar
• Chen, C. COX-2's new role in inflammation. Nat. Chem. Biol. 6, 401–402 (2010).
  CAS PubMed Google Scholar
• Norris, P. C. & Dennis, E. A. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc. Natl Acad. Sci. USA 109, 8517–8522 (2012). A study that confirms the biochemical mechanism of actions of ω- 3 PUFAs on COX1 and COX2 that relate to cardiovascular complications of NSAIDs; a role for PUFA elongation and desaturation is also identified.
  CAS PubMed Google Scholar
• Smith, W. L., DeWitt, D. L. & Garavito, R. M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145–182 (2000).
  CAS PubMed Google Scholar
• Kühn, H. & O'Donnell, V. B. Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45, 334–356 (2006).
  PubMed Google Scholar
• Norris, P. C., Reichart, D., Dumlao, D. S., Glass, C. K. & Dennis, E. A. Specificity of eicosanoid production depends on the TLR-4-stimulated macrophage phenotype. J. Leukocyte Biol. 90, 563–574 (2011).
  CAS PubMed Google Scholar
• Lawrence, T., Willoughby, D. A. & Gilroy, D. W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2, 787–795 (2002).
  CAS PubMed Google Scholar
• Shinomiya, S. et al. Regulation of TNFα and interleukin-10 production by prostaglandins I2 and E2: studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochem. Pharmacol. 61, 1153–1160 (2001).
  CAS PubMed Google Scholar
• Samuelsson, B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220, 568–575 (1983).
  CAS PubMed Google Scholar
• Lammermann, T. et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 498, 371–375 (2013). The definitive study on LTB 4 that demonstrates its ability to markedly enhance neutrophil recruitment to sites of tissue damage.
  PubMed Google Scholar
• Murakami, K., Ide, T., Suzuki, M., Mochizuki, T. & Kadowaki, T. Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor α. Biochem. Biophys. Res. Commun. 260, 609–613 (1999).
  CAS PubMed Google Scholar
• Huang, J. T. et al. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 400, 378–382 (1999).
  CAS PubMed Google Scholar
• Roman, R. J. _P_-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82, 131–185 (2002).
  CAS PubMed Google Scholar
• von Moltke, J. et al. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490, 107–111 (2012). An important demonstration of the life-threatening role that eicosanoids produced by COX1 have in toxic shock, which does not depend on cytokine storms.
  CAS PubMed PubMed Central Google Scholar
• Bitto, A. et al. Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis. Crit. Care 16, R32 (2012).
  PubMed PubMed Central Google Scholar
• Balsinde, J., Balboa, M. A. & Dennis, E. A. Antisense inhibition of group VI Ca2+-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J. Biol. Chem. 272, 29317–29321 (1997).
  CAS PubMed Google Scholar
• Fitzpatrick, F. A. & Soberman, R. Regulated formation of eicosanoids. J. Clin. Invest. 107, 1347–1351 (2001).
  CAS PubMed PubMed Central Google Scholar
• Buczynski, M. W. et al. TLR-4 and sustained calcium agonists synergistically produce eicosanoids independent of protein synthesis in RAW264.7 cells. J. Biol. Chem. 282, 22834–22847 (2007).
  CAS PubMed Google Scholar
• Naraba, H. et al. Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. J. Immunol. 160, 2974–2982 (1998).
  CAS PubMed Google Scholar
• Brock, T. G., McNish, R. W. & Peters-Golden, M. Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2 . J. Biol. Chem. 274, 11660–11666 (1999).
  CAS PubMed Google Scholar
• Mandal, A. K. et al. The nuclear membrane organization of leukotriene synthesis. Proc. Natl Acad. Sci. USA 105, 20434–20439 (2008).
  CAS PubMed Google Scholar
• Kihara, Y. et al. Modeling of eicosanoid fluxes reveals functional coupling between cyclooxygenases and terminal synthases. Biophys. J. 106, 966–975 (2014). An integrated experimental and computational confirmation of the functional coupling mechanisms for the biosynthesis of prostaglandins and thromboxane by COX1, COX2 and downstream enzymes, including the flux of metabolites over time during inflammation.
  CAS PubMed PubMed Central Google Scholar
• Folco, G. & Murphy, R. C. Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses. Pharmacol. Rev. 58, 375–388 (2006).
  CAS PubMed Google Scholar
• Chiang, N., Arita, M. & Serhan, C. N. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot. Essent. Fatty Acids 73, 163–177 (2005).
  CAS PubMed Google Scholar
• Claria, J. & Serhan, C. N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl Acad. Sci. USA 92, 9475–9479 (1995).
  CAS PubMed Google Scholar
• Morris, T. et al. Effects of low-dose aspirin on acute inflammatory responses in humans. J. Immunol. 183, 2089–2096 (2009).
  CAS PubMed Google Scholar
• Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K. & Serhan, C. N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2, 612–619 (2001).
  CAS PubMed Google Scholar
• Chan, M. M. & Moore, A. R. Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J. Immunol. 184, 6418–6426 (2010).
  CAS PubMed PubMed Central Google Scholar
• Gasser, O. & Schifferli, J. A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 104, 2543–2548 (2004).
  CAS PubMed Google Scholar
• Dalli, J. & Serhan, C. N. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 120, e60–e72 (2012).
  CAS PubMed PubMed Central Google Scholar
• Miki, Y. et al. Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators. J. Exp. Med. 210, 1217–1234 (2013).
  CAS PubMed PubMed Central Google Scholar
• Dioszeghy, V. et al. 12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo. J. Immunol. 181, 6514–6524 (2008).
  CAS PubMed Google Scholar
• Li, P. et al. NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids. Cell 155, 200–214 (2013).
  CAS PubMed PubMed Central Google Scholar
• Harmon, G. S. et al. Pharmacological correction of a defect in PPAR-γ signaling ameliorates disease severity in _Cftr_-deficient mice. Nat. Med. 16, 313–318 (2010).
  CAS PubMed PubMed Central Google Scholar
• Mayer-Barber, K. D. & Sher, A. Cytokine and lipid mediator networks in tuberculosis. Immunol. Rev. 264, 264–275 (2015).
  CAS PubMed PubMed Central Google Scholar
• Tobin, D. M. et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140, 717–730 (2010).
  CAS PubMed PubMed Central Google Scholar
• Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99–103 (2014).
  CAS PubMed PubMed Central Google Scholar
• Coulombe, F. et al. Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages. Immunity 40, 554–568 (2014).
  CAS PubMed Google Scholar
• Blaho, V. A., Buczynski, M. W., Brown, C. R. & Dennis, E. A. Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis. J. Biol. Chem. 284, 21599–21612 (2009).
  CAS PubMed PubMed Central Google Scholar
• Blaho, V. A., Zhang, Y., Hughes-Hanks, J. M. & Brown, C. R. 5-lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis. J. Immunol. 186, 3076–3084 (2011).
  CAS PubMed PubMed Central Google Scholar
• Blaho, V. A., Mitchell, W. J. & Brown, C. R. Arthritis develops but fails to resolve during inhibition of cyclooxygenase 2 in a murine model of Lyme disease. Arthritis Rheumatism 58, 1485–1495 (2008).
  CAS PubMed Google Scholar
• Maier, N. K., Leppla, S. H. & Moayeri, M. The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes. J. Immunol. 194, 2776–2785 (2015).
  CAS PubMed PubMed Central Google Scholar
• Chiang, N. et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484, 524–528 (2012). An example of lipid mediator signalling that guards against antibiotic resistance.
  CAS PubMed PubMed Central Google Scholar
• Morita, M. et al. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 153, 112–125 (2013). An extensive study that links a defect in pro-resolving mediator synthesis to compromised immunity to influenza virus.
  CAS PubMed Google Scholar
• Tam, V. C. et al. Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell 154, 213–227 (2013). A report of comprehensive transcriptomics, proteomics and lipidomics carried out during mouse influenza virus infection that identified distinct lipid biomarkers during active infection that are also observed in human influenza virus infections.
  CAS PubMed PubMed Central Google Scholar
• Ramon, S. et al. The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant? J. Immunol. 193, 6031–6040 (2014).
  CAS PubMed PubMed Central Google Scholar
• Aharony, D. Pharmacology of leukotriene receptor antagonists. Am. J. Respiratory Crit. Care Med. 157, S214–218; discussion S218–S219, S247–S248 (1998).
  Google Scholar
• Wang, Y., Armando, A. M., Quehenberger, O., Yan, C. & Dennis, E. A. Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples. Journal of Chromatogr. A. 1359, 60–69 (2014).
  CAS Google Scholar
• Kliewer, S. A. et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl Acad. Sci. USA 94, 4318–4323 (1997).
  CAS PubMed Google Scholar
• Chou, W. L. et al. Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor γ activation. J. Biol. Chem. 282, 18162–18172 (2007).
  CAS PubMed Google Scholar
• Baker, P. R. et al. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J. Biol. Chem. 280, 42464–42475 (2005).
  CAS PubMed PubMed Central Google Scholar
• Groeger, A. L. et al. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat. Chem. Biol. 6, 433–441 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ricciotti, E. & FitzGerald, G. A. Prostaglandins and inflammation. Arterioscler. Thromb. Vascular Biol. 31, 986–1000 (2011).
  CAS Google Scholar
• Passarelli, M. K., Ewing, A. G. & Winograd, N. Single-cell lipidomics: characterizing and imaging lipids on the surface of individual Aplysia californica neurons with cluster secondary ion mass spectrometry. Anal. Chem. 85, 2231–2238 (2013).
  CAS PubMed Google Scholar
• Zemski Berry, K. A., Gordon, W. C., Murphy, R. C. & Bazan, N. G. Spatial organization of lipids in the human retina and optic nerve by MALDI imaging mass spectrometry. J. Lipid Res. 55, 504–515 (2014).
  CAS PubMed PubMed Central Google Scholar
• Fitzgerald, D. J. & Fitzgerald, G. A. Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism. Circul. Res. 112, 174–194 (2013).
  CAS Google Scholar
• Patrono, C. & Baigent, C. Nonsteroidal anti-inflammatory drugs and the heart. Circulation 129, 907–916 (2014).
  PubMed Google Scholar
• Serhan, C. N., Hamberg, M. & Samuelsson, B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc. Natl Acad. Sci. USA 81, 5335–5339 (1984).
  CAS PubMed Google Scholar
• Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N. & Bazan, N. G. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl Acad. Sci. USA 101, 8491–8496 (2004).
  CAS PubMed Google Scholar
• Marcheselli, V. L. et al. Novel docosanoids inhibit brain ischemia–reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278, 43807–43817 (2003).
  CAS PubMed Google Scholar
• Dalli, J., Chiang, N. & Serhan, C. N. Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection. Proc. Natl Acad. Sci. USA 111, E4753–E4761 (2014).
  CAS PubMed Google Scholar
• Morimoto, K. et al. Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation. J. Immunol. 192, 1130–1137 (2014).
  CAS PubMed Google Scholar
• Bray, M. A., Cunningham, F. M., Ford-Hutchinson, A. W. & Smith, M. J. Leukotriene B4: a mediator of vascular permeability. Br. J. Pharmacol. 72, 483–486 (1981).
  CAS PubMed PubMed Central Google Scholar
• Minami, T. et al. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br. J. Pharmacol. 133, 438–444 (2001).
  CAS PubMed PubMed Central Google Scholar
• Lin, C. R. et al. Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity. J. Pharmacol. Exp. Ther. 319, 1096–1103 (2006).
  CAS PubMed Google Scholar
• Moriyama, T. et al. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol. Pain 1, 3 (2005).
  PubMed PubMed Central Google Scholar
• Lazarus, M. et al. EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses. Nat. Neurosci. 10, 1131–1133 (2007).
  CAS PubMed Google Scholar
• Treffkorn, L., Scheibe, R., Maruyama, T. & Dieter, P. PGE2 exerts its effect on the LPS-induced release of TNF-alpha, ET-1, IL-1alpha, IL-6 and IL-10 via the EP2 and EP4 receptor in rat liver macrophages. Prostaglandins Other Lipid Mediat. 74, 113–123 (2004).
  CAS PubMed Google Scholar
• Jakobsson, P. J., Thoren, S., Morgenstern, R. & Samuelsson, B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl Acad. Sci. USA 96, 7220–7225 (1999).
  CAS PubMed Google Scholar
• Cheng, K. et al. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc. Natl Acad. Sci. USA 103, 6682–6687 (2006).
  CAS PubMed Google Scholar
• Liang, X., Wu, L., Hand, T. & Andreasson, K. Prostaglandin D2 mediates neuronal protection via the DP1 receptor. J. Neurochem. 92, 477–486 (2005).
  CAS PubMed Google Scholar
• Taketomi, Y. et al. Mast cell maturation is driven via a group III phospholipase A2–prostaglandin D2–DP1 receptor paracrine axis. Nat. Immunol. 14, 554–563 (2013).
  CAS PubMed PubMed Central Google Scholar
• Spik, I. et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J. Immunol. 174, 3703–3708 (2005).
  CAS PubMed Google Scholar
• Schratl, P. et al. The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking. J. Immunol. 179, 4792–4799 (2007).
  CAS PubMed Google Scholar
• Kliewer, S. A. et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83, 813–819 (1995).
  CAS PubMed Google Scholar
• Forman, B. M. et al. 15-Deoxy-Δ12, 14-prostaglandin _J_2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803–812 (1995).
  CAS PubMed Google Scholar
• Basu, S. Novel cyclooxygenase-catalyzed bioactive prostaglandin F2α from physiology to new principles in inflammation. Med. Res. Rev. 27, 435–468 (2007).
  CAS PubMed Google Scholar
• Woodward, D. F. et al. Prostaglandin F2 alpha effects on intraocular pressure negatively correlate with FP-receptor stimulation. Investigative Ophthalmol. Visual Sci. 30, 1838–1842 (1989).
  CAS Google Scholar
• Moncada, S., Herman, A. G., Higgs, E. A. & Vane, J. R. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb. Res. 11, 323–344 (1977).
  CAS PubMed Google Scholar
• Murata, T. et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388, 678–682 (1997).
  CAS PubMed Google Scholar
• Weiss, H. J. & Turitto, V. T. Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood 53, 244–250 (1979).
  CAS PubMed Google Scholar
• Lim, H. et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev. 13, 1561–1574 (1999).
  CAS PubMed PubMed Central Google Scholar
• Gupta, R. A. et al. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer. Proc. Natl Acad. Sci. USA 97, 13275–13280 (2000).
  CAS PubMed Google Scholar
• Hartwig, J. H. et al. Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 82, 643–653 (1995).
  CAS PubMed Google Scholar
• Auch-Schwelk, W., Katusic, Z. S. & Vanhoutte, P. M. Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension 15, 699–703 (1990).
  CAS PubMed Google Scholar
• Cogolludo, A., Moreno, L., Bosca, L., Tamargo, J. & Perez-Vizcaino, F. Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction: role of protein kinase Cζ. Circul. Res. 93, 656–663 (2003).
  CAS Google Scholar
• Kabashima, K. et al. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4, 694–701 (2003).
  CAS PubMed Google Scholar
• Iizuka, Y. et al. Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitis. FASEB J. 24, 4678–4690 (2010).
  CAS PubMed Google Scholar
• Narala, V. R. et al. Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor-α agonist. J. Biol. Chem. 285, 22067–22074 (2010).
  CAS PubMed PubMed Central Google Scholar
• Devchand, P. R. et al. The PPARα–leukotriene B4 pathway to inflammation control. Nature 384, 39–43 (1996).
  CAS PubMed Google Scholar
• Moos, M. P. et al. Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport. FASEB J. 22, 4352–4362 (2008).
  CAS PubMed Google Scholar
• Hwang, S. W. et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl Acad. Sci. USA 97, 6155–6160 (2000).
  CAS PubMed Google Scholar
• Ng, V. Y. et al. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor α. Drug Metabolism Dispos. 35, 1126–1134 (2007).
  CAS Google Scholar
• Liu, Y. et al. The antiinflammatory effect of laminar flow: the role of PPARγ, epoxyeicosatrienoic acids, and soluble epoxide hydrolase. Proc. Natl Acad. Sci. USA 102, 16747–16752 (2005).
  CAS PubMed Google Scholar
• Inceoglu, B., Schmelzer, K. R., Morisseau, C., Jinks, S. L. & Hammock, B. D. Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs). Prostaglandins Other Lipid Mediat. 82, 42–49 (2007).
  CAS PubMed Google Scholar
• Gregus, A. M. et al. Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proc. Natl Acad. Sci. USA 109, 6721–6726 (2012).
  CAS PubMed Google Scholar
• Mrsny, R. J. et al. Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proc. Natl Acad. Sci. USA 101, 7421–7426 (2004).
  CAS PubMed Google Scholar
• Hurley, B. P., Siccardi, D., Mrsny, R. J. & McCormick, B. A. Polymorphonuclear cell transmigration induced by Pseudomonas aeruginosa requires the eicosanoid hepoxilin A3 . J. Immunol. 173, 5712–5720 (2004).
  CAS PubMed Google Scholar
• Nigam, S., Zafiriou, M. P., Deva, R., Ciccoli, R. & Roux-Van der Merwe, R. Structure, biochemistry and biology of hepoxilins: an update. FEBS J. 274, 3503–3512 (2007).
  CAS PubMed Google Scholar
• Hammond, V. J. & O'Donnell, V. B. Esterified eicosanoids: generation, characterization and function. Biochim. Biophys. Acta 1818, 2403–2412 (2012).
  CAS PubMed Google Scholar
• Brezinski, M. E. & Serhan, C. N. Selective incorporation of (15_S_)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids. Proc. Natl Acad. Sci. USA 87, 6248–6252 (1990).
  CAS PubMed Google Scholar
• Rouzer, C. A. & Marnett, L. J. Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. J. Biol. Chem. 283, 8065–8069 (2008).
  CAS PubMed PubMed Central Google Scholar
• Trostchansky, A. et al. Nitroarachidonic acid, a novel peroxidase inhibitor of prostaglandin endoperoxide H synthases 1 and 2. J. Biol. Chem. 286, 12891–12900 (2011).
  CAS PubMed PubMed Central Google Scholar